Research programme: anti-infectives - Clinical Data/VDDI
Latest Information Update: 03 Apr 2007
At a glance
- Originator University of Alabama
- Developer Clinical Data
- Class
- Mechanism of Action Nicotinamide adenine dinucleotide antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anthrax
Most Recent Events
- 20 Dec 2005 Icoria has been acquired and merged into Clinical Data
- 24 Aug 2004 Paradigm Genetics is now called Icoria
- 02 Apr 2002 Preclinical trials in Anthrax in USA (PO)